Tislelizumab Biosimilar - Research Grade
Product Specifications
Background
Product Name Alternative
Programmed cell death protein 1, Pdcd1, CD279
UniProt
Q15116
Host
Humanized
Reactivity
Human
Target
PD-1
Isotype
IgG4
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
<1 EU/mg Determined by LAL gel clotting assay
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
Specificity
Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tislelizumab.
Formulation
Phosphate buffered saline (PBS) pH 7.2, with no carrier protein, potassium or preservatives added. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
Explore Other Products
Browse additional items from our catalog
LGR5, NT (LGR5, GPR49, GPR67, Leucine-rich repeat-containing G-protein coupled receptor 5, G-protein coupled receptor 49, G-protein coupled receptor 67, G-protein coupled receptor HG38) (MaxLight 750) discontinued
KvLQT1 (Potassium Voltage-gated Channel Subfamily KQT Member 1, KCNQ1, ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS) (PE)
KvLQT1 (Potassium Voltage-gated Channel Subfamily KQT Member 1, KCNQ1, ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS) (PE)
DFNA37 sgRNA CRISPR Lentivector (Human) (Target 1)
CBF, CT (CCAAT/Enhancer-binding Protein zeta, CCAAT-box-binding Transcription Factor, CCAAT-binding Factor, CBF, CEBPZ, CBF2) (MaxLight 650)